7th Clinical Trials Innovation Programme

7th Clinical Trials Innovation Programme

The 7th Clinical Trials Innovation Programme (CTIP): Helping You Achieve Excellence Through Innovation is an invitation-only event for senior executives from the pharmaceutical and biotechnology industries. Companies with representation at the conference are 45% small or startup, 30% mid-size, and 25% large multinational corporations.

Gerald Yakatan, Ph.D., Chairman, CEO and founder of IriSys, will be a featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme in Boston, MA on May 17, 2017. Dr. Yakatan’s talk, “Where Have All the New Drugs Gone: A Model for Improving the Efficiency and Costs of Pharmaceutical R&D,” will describe the custom approach to drug development that helps differentiate IriSys from other contract organizations.

“Improving the efficiency and costs of pharmaceutical research and development is important for companies of all sizes and capabilities,” said Gerald Yakatan, Ph.D., IriSys Chairman, CEO and founder. “IriSys has a wide range of U.S. and international clients, partners and collaborators who come to us because we are experienced in bringing products to the market quickly and cost-effectively. Our decades of pharmaceutical R&D expertise allow IriSys to meet or exceed their timelines while accommodating change.”

The CTIP conference attendees span CEOs, Vice Presidents, Directors, and departmental heads. The program includes networking opportunities and one-on-one meetings during which the attendees can confer with Dr. Yakatan and the other “Thought Leaders.”

Date

May 17 2017

Location

Boston, MA
Boston, MA